Table 3.
Patients’ N/L ratios
| All patients n (%) | Group 1 n (%) | Group 2 n (%) | p-value | |
|---|---|---|---|---|
| N/L ratio | 8.85±6.05 | 9.1±6.1 | 8.75±6.15 | 0.976 |
| (0.49–24.19) | (1.26–21.81) | (0.49–24.19) |
N/L: Neutrophil-lymphocyte.
Patients’ N/L ratios
| All patients n (%) | Group 1 n (%) | Group 2 n (%) | p-value | |
|---|---|---|---|---|
| N/L ratio | 8.85±6.05 | 9.1±6.1 | 8.75±6.15 | 0.976 |
| (0.49–24.19) | (1.26–21.81) | (0.49–24.19) |
N/L: Neutrophil-lymphocyte.